Tesla Shareholders to Vote on $5 Billion xAI Investment

Generated by AI AgentCoin World
Monday, Jul 14, 2025 7:54 am ET1min read

Tesla CEO Elon Musk has proposed that shareholders vote on whether the electric vehicle company should invest in his artificial intelligence startup, xAI. This vote is expected to take place at Tesla's annual meeting, scheduled for November. The news comes as Musk's SpaceX company reportedly contributed $2 billion to xAI's recent $10 billion fundraising round, which included both equity and debt.

Musk has expressed his desire for

to invest in xAI, stating that he would have done so already if it were up to him. The company behind Grok, xAI, is investing heavily to challenge OpenAI and its ChatGPT in the development of artificial general intelligence. Musk recently unveiled the fourth generation of the Grok chatbot, which is being integrated into Tesla vehicles.

SpaceX's investment in xAI, despite limited business rationale, highlights Musk's interest in consolidating control over his business empire. Musk had previously polled his social media followers on whether Tesla should invest $5 billion in xAI, with two-thirds of respondents in favor. However, the governance implications of using Tesla shareholders' money for such an investment are complex, given the potential conflict of interest and exposure to risks associated with xAI's other ventures, such as the acquisition of X, formerly known as Twitter.

xAI's aggressive spending on research and development has raised concerns about its financial sustainability. The startup is expected to burn through about $13 billion in cash this year, according to reports. Despite these challenges, some analysts have argued in favor of Tesla investing in xAI, citing the potential for significant shareholder value in the AI sector. However, the governance and reputational risks associated with such an investment cannot be overlooked, as evidenced by the recent controversies surrounding Grok and xAI's other ventures.

Comments



Add a public comment...
No comments

No comments yet